WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsHaemonetics Corporation (HAE)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 1473% more annual revenue ($21.27B vs $1.35B). GEHC leads profitability with a 9.3% profit margin vs 7.1%. GEHC appears more attractively valued with a PEG of 1.77. GEHC earns a higher WallStSmart Score of 65/100 (C+).

GEHC

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 6.5Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

HAE

Hold

50

out of 100

Grade: D+

Growth: 4.7Profit: 6.0Value: 5.3Quality: 6.5
Piotroski: 4/9Altman Z: 1.51
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEHC.

HAEUndervalued (+34.3%)

Margin of Safety

+34.3%

Fair Value

$87.57

Current Price

$120.28

$32.71 discount

UndervaluedFair: $87.57Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC1 strengths · Avg: 8.0/10
P/E RatioValuation
16.3x8/10

Attractively priced relative to earnings

HAE0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.774/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$-617.00M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

HAE4 concerns · Avg: 3.8/10
PEG RatioValuation
1.904/10

Expensive relative to growth rate

EPS GrowthGrowth
2.9%4/10

2.9% earnings growth

Altman Z-ScoreHealth
1.514/10

Distress zone — elevated risk

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio.

Bull Case : HAE

HAE has a balanced fundamental profile.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Free Cash Flow.

Bear Case : HAE

The primary concerns for HAE are PEG Ratio, EPS Growth, Altman Z-Score. A P/E of 57.2x leaves little room for execution misses.

Key Dynamics to Monitor

GEHC carries more volatility with a beta of 0.85 — expect wider price swings.

GEHC is growing revenue faster at 5.8% — sustainability is the question.

HAE generates stronger free cash flow (44M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GEHC scores higher overall (65/100 vs 50/100). HAE offers better value entry with a 34.3% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Haemonetics Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?